SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-23-009599
Filing Date
2023-03-30
Accepted
2023-03-30 08:05:24
Documents
14
Period of Report
2023-03-30
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 40009
2 ex99-1.htm EX-99.1 102826
3 ex99-1_001.jpg GRAPHIC 3218
  Complete submission text file 0001493152-23-009599.txt   338739

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE imnn-20230330.xsd EX-101.SCH 3221
5 XBRL LABEL FILE imnn-20230330_lab.xml EX-101.LAB 34240
6 XBRL PRESENTATION FILE imnn-20230330_pre.xml EX-101.PRE 22355
8 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3608
Mailing Address 997 LENOX DRIVE SUITE 100 LAWRENCEVILLE NJ 08648
Business Address 997 LENOX DRIVE SUITE 100 LAWRENCEVILLE NJ 08648 (609) 896-9100
Imunon, Inc. (Filer) CIK: 0000749647 (see all company filings)

IRS No.: 521256615 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-15911 | Film No.: 23777216
SIC: 2834 Pharmaceutical Preparations